22 May 2013
Keywords: medimmune, files, maa, laiv, global, biologics, unit
Article | 12 January 2009
MedImmune, the global biologics unit of Anglo-Swedish drug major AstraZeneca, has submitted a Marketing Authorisation Application for its
nasal spray ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
21 May 2013
© 2013 thepharmaletter.com